Crowdsourcing Consensus on the Utilisation of Antiplatelet Therapy in NSTE-ACS
Join the Crowd
Join your colleagues from across the globe to influence the way in which NSTE-ACS patients are managed post-PCI.
- Overview
- Steering Committee
- Pre-Reading Materials
Overview
On behalf of the International Society of Cardiovascular Pharmacotherapy (ISCP) and Radcliffe Medical Education, thank you for your interest in taking part in this innovative crowdsourcing project, made possible with an unrestricted educational grant from AstraZeneca.
You will appreciate the important role clinical guidelines play in the practice of medicine. However, they are often outdated in relation to the latest data and empirical evidence. To address this, we are taking a novel crowdsourcing approach to pool the insight and practices of cardiologists from across the globe and will distil the prevailing beliefs and practices in a consensus statement, which we are aiming to publish in a peer reviewed journal in early 2021. The specific area of focus is on the use of monotherapy and DAPT in NSTE-ACS patients at high bleeding risk.
Based upon critical emerging data, the ISCP, in partnership with Radcliffe Medical Education, proposes an innovative crowdsourcing methodology, to create and publish a sound practice-based consensus on the treatment of high bleeding risk NSTE-ACS patients, following PCI.
To help shape this we are looking to recruit thought-leader cardiologists and other prescribers from across the globe to complete this survey. Interested participants should:
- currently manage ACS patients
- be able to prescribe antiplatelet therapy
- have an understanding of ACS/antiplatelet literature
Registration for this project has now closed.
We are currently analysing the data and looking forward to sharing the results with you later this year.
Steering Committee
To execute this exciting project, the Steering Committee of leading, global experts in ACS, alongside the valuable input of the crowd, will develop practice-based consensus and high-quality educational material for global dissemination.
Professor Juan Carlos Kaski – Chair
Professor of Cardiovascular Science at St George’s, University of London (SGUL), Honorary Consultant Cardiologist at St George’s Hospital, NHS Trust, London, UK and Director of the Cardiovascular and Cell Sciences Research Institute at SGUL. Immediate Past-President of ISCP (International Society of Cardiovascular Pharmacotherapy)
Professor Deepak Bhatt – Co-Chair
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center, Professor of Medicine, Harvard Medical School
Dr Mirvat Alasnag
Director Catheterization Laboratory, King Fahd Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia, SCAI International Ambassador, ACC Interventional Leadership Council
Professor Felicita Andreotti
Professor of Cardiovascular Medicine, Institute of Cardiology, Catholic University Medical School, Rome, Italy
Professor Dominick J. Angiolillo
Professor of Medicine, Director, Cardiovascular Research, Program Director, Interventional Cardiology Fellowship, University of Florida College of Medicine
Professor Albert Ferro
Professor of Cardiovascular Clinical Pharmacology, King’s College London, London, UK
Professor Diana Gorog
Consultant Cardiologist, East and North Hertfordshire NHS Trust & Professor of Cardiovascular Medicine, University of Hertfordshire, UK
Dr Alberto J. Lorenzatti
President of the Argentine Federation of Cardiology, Co-Director, DAMIC Medical Institute / Rusculleda Foundation for Research in Medicine, Argentina
Professor Mamas Mamas
Professor of Cardiology, Keele University, UK
Professor John McNeil
Head of Department of Epidemiology and Preventive Medicine, Head of School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Professor José C. Nicolau
Professor of University of Sao Paulo, Brazil & Director of Acute Coronary Diseases Unit, Heart Institute (InCor)
Professor Philippe Gabriel Steg
Chief, Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, in Paris, France
Professor Juan Tamargo
Professor of Pharmacology at the Faculty of Medicine of the Complutense University of Madrid, Madrid, Spain
Associate Professor Doreen Tan
Associate Professor, Clinical & Pharmacy Practice, Cardiology Specialist Pharmacist, Department of Pharmacy, National University of Singapore
Pre-Reading Materials
As we will be asking for your input on a number of existing clinical trials and guidelines during the survey, you may find it helpful to familiarise yourself with the following publications. Algorithms and passages from the relevant guidelines will be accessible at specific points throughout the survey.
Clinical trials:
GLOBAL LEADERS
Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31858-0/fulltextACCESS CONTENT 
SMART-CHOICE
Available at: https://jamanetwork.com/journals/jama/article-abstract/2736564ACCESS CONTENT
SMART-DATE
Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30493-8/fulltextACCESS CONTENT
Clinical guidelines:
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Available at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-Coronary-Syndromes-ACS-in-patients-presenting-without-persistent-ST-segmACCESS CONTENT
2011 American College of Cardiology Foundation/American Heart Association/The Society for Cardiovascular Angiography and Interventions (ACCF/AHA/SCAI) Guideline
Available at: https://www.ahajournals.org/doi/10.1161/CIR.0b013e31823ba622ACCESS CONTENT
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Available at: https://www.onlinejacc.org/content/68/10/1082ACCESS CONTENT
Register Now For Free 
© Radcliffe Cardiology. All rights reserved.
Contact us | Terms and Conditions | Privacy Policy
NSTE-ACS: Non-ST elevation acute coronary syndrome